XOMA Royalty Enters into Agreement to Acquire LAVA Therapeutics for Between $1.16 and $1.24 Per Share in Cash, Plus a Contingent Value Right

XOMA Royalty to Acquire LAVA for between $1.16 and $1.24 per share in cash plus a CVR.